1. [The efficacy of rinopront for the treatment of acute and chronic rhinitis in the children].
- Author
-
Chistiakova VR and Miasnikov LL
- Subjects
- Acute Disease, Administration, Oral, Adolescent, Child, Chronic Disease, Drug Combinations, Female, Histamine H1 Antagonists administration & dosage, Histamine H1 Antagonists adverse effects, Humans, Male, Maxillary Sinusitis complications, Maxillary Sinusitis etiology, Maxillary Sinusitis physiopathology, Nasal Decongestants administration & dosage, Nasal Decongestants adverse effects, Rhinitis complications, Rhinitis etiology, Rhinitis physiopathology, Severity of Illness Index, Time Factors, Treatment Outcome, Maxillary Sinusitis drug therapy, Nasal Mucosa drug effects, Phenylephrine administration & dosage, Phenylephrine adverse effects, Pyridines administration & dosage, Pyridines adverse effects, Rhinitis drug therapy
- Abstract
The objective of the present study was to estimate the therapeutic efficacy of rinopront used to treat inflammatory diseases of the nasopharynx in the children. The study included 32 patients at the age between 12 and 14 years presenting with various forms of acute and chronic rhinitis. The children with infectious inflammatory rhinitis with concomitant catarrhal maxillary sinusitis and pronounced symptoms of rhino-conjunctival syndrome recovered within 4-5 days after the initiation of rhinopront therapy. The patients presenting with vasomotor and all-the-year-round allergic rhinitis needed two courses of treatment (5 days each) to recover. The duration of treatment of mild seasonal rhinitis was 4 days whereas the moderately severe disease required the second 5-day course of therapy to be performed to arrest the disease activity.
- Published
- 2012